What is 10x Genomics, Inc.'s PP&E (net)?

10x Genomics, Inc. (TXG) reported PP&E (net) of $220.59M in Q1 2026.

How has 10x Genomics, Inc.'s PP&E (net) changed year-over-year?

10x Genomics, Inc.'s PP&E (net) decreased by 10.4% year-over-year, from $246.09M to $220.59M.

What is the long-term trend for 10x Genomics, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), 10x Genomics, Inc.'s PP&E (net) has grown at a 25.5% compound annual growth rate (CAGR), from $72.84M to $226.71M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

10x Genomics, Inc. TXG PP&E (Net)

PP&E (Net) at other companies

TEC

Bio-TechneTECH

$232.99M-7.5%

BrukerBRKR

$719.6M+4.4%

IlluminaILMN

$755M-3.5%

Twist Bioscience CorporationTWST

$111.23M+14.5%

RevvityRVTY

$465.64M-4.3%

Bio-Rad LaboratoriesBIO

$527.5M-0.2%

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s PP&E (net)?: 10x Genomics, Inc. (TXG) reported PP&E (net) of $220.59M in Q1 2026.
How has 10x Genomics, Inc.'s PP&E (net) changed year-over-year?: 10x Genomics, Inc.'s PP&E (net) decreased by 10.4% year-over-year, from $246.09M to $220.59M.
What is the long-term trend for 10x Genomics, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), 10x Genomics, Inc.'s PP&E (net) has grown at a 25.5% compound annual growth rate (CAGR), from $72.84M to $226.71M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.